Vincent J. Angotti - 11 Sep 2023 Form 4 Insider Report for ACELRX PHARMACEUTICALS INC (TLPH)

Role
Chief Executive Officer, Director
Signature
/s/ Martha Adler, Attorney-In-Fact
Issuer symbol
TLPH
Transactions as of
11 Sep 2023
Net transactions value
+$7,950
Form type
4
Filing time
11 Sep 2023, 19:13:26 UTC
Previous filing
06 Mar 2023
Next filing
14 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRX Common Stock Purchase $7,950 +10,000 +12% $0.7950 91,805 11 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance includes non-reportable acquisitions of 7,969 and 10,000 shares of Common Stock through the Company's Employee Stock Purchase Plan on February 28, 2023 and August 31, 2023, respectively.